2-(2'-Amino-2'-deoxy-beta-D-glucopyranosyl)-benzimidazole

ID: ALA4098082

PubChem CID: 137660191

Max Phase: Preclinical

Molecular Formula: C13H17N3O4

Molecular Weight: 279.30

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1c1nc2ccccc2[nH]1

Standard InChI:  InChI=1S/C13H17N3O4/c14-9-11(19)10(18)8(5-17)20-12(9)13-15-6-3-1-2-4-7(6)16-13/h1-4,8-12,17-19H,5,14H2,(H,15,16)/t8-,9-,10-,11-,12-/m1/s1

Standard InChI Key:  LYIYMLSLDLTKMD-LZQZFOIKSA-N

Molfile:  

     RDKit          2D

 20 22  0  0  0  0  0  0  0  0999 V2000
   44.0093  -24.1952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.0093  -25.8428    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   42.5806  -26.6667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   41.1560  -25.8429    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   42.5805  -24.1952    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   40.5331  -24.7284    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   43.2990  -24.6071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.2990  -25.4309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.5805  -25.8429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.8704  -25.4310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.8704  -24.6072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.1560  -24.1953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.7583  -24.5292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   44.0944  -23.3785    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   44.8960  -23.2088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.3005  -23.9169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.1147  -23.9176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.5253  -23.2109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.1118  -22.5021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.2989  -22.5049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  6 12  1  0
 11  5  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  1
  7  1  1  1
  8  2  1  6
  9  3  1  1
 10  4  1  6
  1 13  2  0
 13 16  1  0
 15 14  1  0
 14  1  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4098082

    ---

Associated Targets(non-human)

PYGM Glycogen phosphorylase, muscle form (1331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 279.30Molecular Weight (Monoisotopic): 279.1219AlogP: -0.96#Rotatable Bonds: 2
Polar Surface Area: 124.62Molecular Species: NEUTRALHBA: 6HBD: 5
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.06CX Basic pKa: 8.27CX LogP: -1.38CX LogD: -2.30
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.48Np Likeness Score: 0.48

References

1. Bokor É, Kyriakis E, Solovou TGA, Koppány C, Kantsadi AL, Szabó KE, Szakács A, Stravodimos GA, Docsa T, Skamnaki VT, Zographos SE, Gergely P, Leonidas DD, Somsák L..  (2017)  Nanomolar Inhibitors of Glycogen Phosphorylase Based on β-d-Glucosaminyl Heterocycles: A Combined Synthetic, Enzyme Kinetic, and Protein Crystallography Study.,  60  (22): [PMID:28925695] [10.1021/acs.jmedchem.7b01056]

Source